chrisvoncsefalvay/vaers-outcomes huggingface dataset:
States about an hour after the shot went back to work-was sitting there-felt warm & fuzzy-the next thing he woke up-was on the floor-staff called 911-was taken to ER-states had coughing & couldn't catch his breath & apparently passed out.
Soreness at injection site beginning about 2 hours after vaccination.  Intermittent mild to moderate body aches and chills starting about 6 hours after vaccination and lasting approximately 24 hours from onset.  Headache,  fatigue and dizziness starting about 16 hours after vaccination and lasting approximately 24 hours from onset.  All symptoms were gone within 48 hours.  Treated with 2 Advil about every 6 hours, which seemed to reduce severity.
10 days after second Pfizer vaccine, patient developed right sided chest pain and shortness of breath. A CT angio confirms a pulmonary embolism.
Patient sent to the ED with shortness of breath and weakness.  Patient admitted to the hospital with Covid and UTI.  Patient treated with remdesivir.
Patient reports swelling at injection site (up to tennis ball size), sensitive and warm to touch; fatigue, aching, joints and muscle pain. Swelling worsened on 6/2/18, patient visited physician and received Prednisone to treat (30 mg for 5 days).
6.5cm erythema around injection site with pain, although no induration, a hard center is felt.
Initial report received from a healthcare professional on 01 November 2013. A 38-year-old female patient had intramuscularly received a dose of FLUZONE (batch number: UH895AA, dose in series was not reported) in the left deltoid on 30 October 2013. The patient had no illness at time of vaccination and had a medical history of hypertension and migraines. Concomitant medication were not reported. On 31 October 2013, few hours after vaccination the patient developed rash that developed into hives and was very itchy. No laboratory tests were done and the patient had received Medrol dose pack as corrective treatment. At the time of this report, the patient was not recovered. It was reported the patient was not recovered. It was reported the patient required ER/doctor visit. List of documents held by sender: None. Follow information received on 06 January 2014. The patient rash was resolving and had developed headache and weakness in arm on an unspecified date. The FLUZONE vaccine expiry date was 30 June 2014. The patient had a history of chills/rigors, vertigo, nausea and headache. The patient had taken flu shot before. The patient was currently married and had 2 sons. The patient smokes every day. The patient had a surgery of dilation and curettage. The patient did not have any severe life threatening allergy to eggs, had no Guillain-Barre Syndrome (within 6 weeks of previous flu vaccine), the patient never had a severe reaction to the flu vaccine and the patient was not ill with a fever greater than 100 degree. The patient's father had a medical history of Alzheimer's disease and cerebrovascular accident CVA (stroke). The patient' mother had a medical history of Diabetes and CAD Coronary artery disease. On an unspecified date the patient's physical examination was done that included: The patient constitutional was normal (well developed), ear: normal, respiratory was normal (inspection, efforts and auscultation was normal), cardiovascular was normal (regular rate and rhythm, no murmurs, gallops or rubs), vascular was normal (pulses, Dorsalis pedis was normal), Abdomen was normal (inspection, auscultation was normal and no abdominal tenderness), skin was red diffuse, patch slightly raised across abd and extremity was normal (no edema). Vital signs included: The patient was 89.811 kg, blood pressure was 128/86 mm/hg and pulse was 60beats/min. The patient received orally Prednisone (0.5mg/kg) 20mg, every day for 4 days, metoprolol tartrate (orally 100mg tablet 1 times every day with meal), Hydrochlorothiazide (orally 25 mg tablet every day), Lisinopril (orally 40 mg 2 tablet every day), Triamcinolone Aceonide (thin film of 0.1% was applied to the affected skin areas 1 to 2 times every day), ZYRTEC (orally 10 mg tablet every morning), FIORICET (50mg-325mg-40mg, one tablet by oral route every 4 hours as needed not to exceed 6 tablets per 24 hours) and BENADRYL. Follow up information received on 07 February 2014. The event of rash was resolved on 06 November 2013 and the reporter had no record of weakness in arm.
pt recv vax; vax was given ID to rt deltoid (misuse) arm is red & a little swollen around inject site;
Baby started crying and I noticed large accumulation of hives all over her legs, which continued to spread throughout her body. The hives came and went for days, baby was in general not feeling good. In the weeks after she was getting sick with cold and flu like symptoms for months, hives coming and going, developed a severe bronchial infection. We tried boosting her immune system and children's BENADRYL when hives were severe.
Non noted at the time. Pt told this nurse that her age was 65 years old at the time of vaccination.
i received the vaccine at 3pm on monday april 12th. i started shaking less than 5 minutes after i received the dose and my throat started to swell and i couldn?t swallow. they placed me under observation for 30 minutes and gave me water?saying that ?i might just be afraid of the needle and not to worry, this is an abnormally normal reaction to a new vaccine.? after 30 minutes a man walked over to me and said ?oh you?re still here?? and chuckled. they then told me i would be fine after a while and to leave. i started walking down the sidewalk and almost passed out so i called an uber to take me to the nearest urgent care. i arrived at urgent care around 4pm unable to swallow and having a reaction to the vaccine. they saw me immediately and gave me 3 50mg of prednisone and a benadryl and placed me under observation for 45 minutes. he said i looked better and i even felt marginally better. i called another uber and when i was almost home my tongue started to go numb as well as my lips and my breathing was becoming constricted. i had the uber driver pull over as i had to sit on the sidewalk and get some air. i then called another uber to the hospital because my symptoms were becoming increasingly more alarming. Hospital admitted me and gave me a shot of epinephrine and IV fluids and kept me under observation for 6 hours. they discharged me a little after midnight with a prescription for prednisone, epinephrine, and benadryl. if i had been administered epinephrine at the vaccine site on monday and not been told i was just squeamish by the male air force cadets?i probably wouldn?t still be short of breath, painfully swallowing, and bedridden.
Patient had onset of one large (5 cm) raised hive that was warm and tender to touch 1 hour after injection. Raised area grew to 7 cm and remained for 6 days. Patient was treated with Benadryl. On the 6th day, the large hive was replaced by 10 or more smaller hives ranging in size from 3 mm to 1.5 cm in a 7cm×7cm area. The following morning the hives had spread to 12cm×12cm area and were too numerous to count. A call was made to the administering practitioner's office to report reaction.
Narrative: Patient received second dose of covid vaccine. Within 15 mins of vaccine administration, patient developed SOB and dizziness. Patient was at facility and was transported via ambulance after EMS was called. No additional details of adverse event available.
My lumpy nodes swelled.  My left shoulder and neck was swollen.  I had hives on my back, stomach, and neck. It made me have a 25 days period.  I had swollen in my fingers and hands. I went to my doctor about this.  The swollen lasted for about 5 days or so.  They did blood test and x-ray of my feet and fingers. I also had a headache.  Now I am anemia because of the long period.  I also have auto immune disorder as well.
The next morning I woke up with dizziness.   I experienced vertigo/dizziness over the course of a couple weeks.  Frequency of vertigo/dizziness began to decline after 5 days and was gone after about 10-12 days.  I've never had vertigo before, and was not expecting it as a side-effect either.
Patient developed diffuse urticaria and facial swelling after receiving Menactra vaccine at Dr's office. Required sq epinephrine. IV Benadryl and decadron.
Numbness, Tingling, wide spread pain and burning. Joint Pain, Small Fiber Nuropathy!
Fully vaccinated patient who admitted through ED with bowel obstruction.  Incidentally tested positive for COVID upon admission.  No respiratory symptoms during stay.  Provider d/c note below:  "Patient is a 93-year-old female with a past medical history of a left lower quadrant ostomy with external hernia.  She was found to have recurrence of small-bowel obstruction related to hernia.  General surgery was consulted, appreciate recommendations.  She had an NG tube which was eventually clamped and her diet advanced.  She tolerated a regular diet with no recurrence of abdominal pain or nausea.  She had a large bowel movement and wanted to return home.  Discussed with General surgery, hoping to avoid surgery, but if this happens again and does not resolve with conservative management will have to consider.  She can follow up with Doctor as needed.   Patient was positive for COVID-19, asymptomatic and has previously been vaccinated with 3 doses.  She did not require any oxygen during hospital stay."
Typical. Redness, soreness -swelling - itching - Resolved within a few days-. Patient wanted to report it.
Patient was waiting in the pharmacy about 5 minutes after the vaccines were given when she stated her vision started to get blurry and dark.  She had difficulty hearing.  She got up and called for help and then sat down in a few feet away.  She then said she felt sick and within seconds she vomited.  This whole episode lasted about 15 seconds from start to finish.  After she vomited she began to calm down and her vision returned to normal.  I checked her blood pressure and HR.  98/65, 54bpm.  She was observed for another 30 minutes.  During that time she did not show anymore signs or symptoms of an adverse response.  Color returned to her face and she stated her vision and hearing had returned to normal.
Parent called 6/13/14 to report child woke up to a red, swollen, "baseball" size lump on right thigh. No c/o shortness of breath or wheezing. Afebrile. Spoke with parent today 6/18/14 still has "bruise" to right thigh, doing well. Did not develop rash had slight fever and c/o it "hurting" treated with ice and ibuprofen.
Eye bulging, face swelling, tachycardia.  ER visit to stabilize, Opthomologist for eye bulge, Primary care doctor for further testing, blood labs, endocrinologist visit and additional labs. Vision care for vision loss.
Patient reports that a rash developed on her chest about a week after receiving influenza vaccine. The patient has sought no treatment for the rash. It has yet to resolve.
Administered with an expired vaccine; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered with an expired vaccine).    No concomitant medications were reported. The vial was initially stored in refrigerator on 07-Jun-2022. The date for the patient vaccine administration was not known, and it was also unknown whether the patient took first, second or first and second booster doses.  It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates on which vaccinations were given from 01-Apr-22, 05-Apr-22, 08-Apr-22, 06-Apr-22, 11-Apr-22, 12-Apr-22, 13-Apr-22, 14-Apr-22, 22-Apr-22, 09-Jun-22, 10-Jun-22, 13-Jun-22, 18-Jun-22, and 22-Jun-22. The vial had not undergone any temperature excursions. No treatment medications were reported.
I had normal aches and pains but when I went in to my immunologist, he said I had a heart murmur. Otherwise, I just had normal symptoms. Until I went to him, I didn't know I had this. Said my aortic valve was bicuspid and had an aneurysm.
Narrative: Patient received COVID vaccine on 1/28/2021, and reports diarrhea and headache on 2/2/ for x3 days. Denies fever, rash, swelling, cough, SOB
This spontaneous report was received from a healthcare worker and refers to unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates ranging from 15-JAN-2016 to 03-MAR-2016 (previously reported as 02-JAN-2016 to 16-MAR-2016), the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # L018351, expiration date 11-AUG-2017, exact dose, route of administration and anatomical location were not reported). The administered doses experienced a temperature excursion of 48.2 to maximum 57 degrees Fahrenheit ranging from 02-JAN-2016 to 29-JAN-2016 (total time 276 hours cumulative). No previous excursion were reported. This is one of several reports received from the same reporter. Additional information has been requested.
tired; Headache; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced headache on 15Feb2021 and was tired on 16Feb2021. The patient stated "I had my first shot yesterday and last night I had a headache and today I been very tired. I actually had to take a nap in the afternoon."  The outcome of events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Low grade fever; Diarrhea; Soreness; nausea; lethargy.; Dry heaves; This case was reported by a consumer via call center representative and described the occurrence of fever in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   In September 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml and the 1st dose of Influenza vaccine Quadrivalent unspecified season .5 ml. On 13th October 2020, less than 3 weeks after receiving Shingrix and Influenza vaccine Quadrivalent unspecified season, the patient experienced dry heaves. On an unknown date, the patient experienced fever, diarrhea, pain, nausea and lethargy. On an unknown date, the outcome of the fever, diarrhea, pain, nausea and lethargy were not recovered/not resolved and the outcome of the dry heaves was unknown.   The reporter considered the fever, diarrhea, pain, nausea and lethargy to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season. It was unknown if the reporter considered the dry heaves to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The patient received both the Shingrix and the Flu vaccine the last week of September in left arm and about 4 hours after the injections, she began to experience low grade fever, diarrhea, soreness, nausea and lethargy.   The reporter reported symptoms had gotten worse over past 3 weeks.  The patient experienced dry heaves.  The reporter provided medical disclaimer and advised her to follow up with her physician and copy of PI sent via email.  The reporter also informed could HCP follow up with GSK Medical Information department for any further questions. The reporter consented to follow up.
This spontaneous report as received from a other health professional refers to a 28 years old male patient. The patient was vaccinated with, 1 DF MMR II. No other co-suspects were reported. No concomitant medications were reported. On 14-NOV-2012 the patient experienced patient's titer for measles was low. No treatment information was reported. The outcome of patient's titer for measles was low is unknown. The relatedness for patient's titer for measles was low is unknown for MMR II> Additional information has been requested./Additional information is not expected.
Pt stated on the 25th , the next day, she developed rash in deltoid area, and was warm and red. By the 27th, she stated she started itching throughout her body
I tested positive for COVID on 8/2/2021 Cough, coughing spasms, thick mucous that I was coughing up- started off as green now is clear, shortness of breath, extreme fatigue, increased sleep, nausea, mild headache at first, decreased appetite, over all feeling of just not feeling right  Monoclonal antibody infusion on 8/6/2021 at 1:00PM  I was off work for 3 weeks from 8/2/2021 and went back on 8/24/2021 I continue with residual symptoms of cough, shortness of breath and fatigue I was put on Tessalon Perrls which did help  some with the coughing, used cough drops, drank lots of water,
Patient was given Flumist in clinic. She has had Flumist in the past without any adverse reaction. Shortly after leaving clinic, she became light-headed and fainted, with her brother and mother catching her so she did not fall. Patient denies loss of consciousness, but mother states patient briefly lost consciousness.  Brought back to clinic with assistance of mother and brother. BP initially 94/64, pulse 57 and regular. Patient oriented to time, place and person. Denied shortness of breath, swelling of mouth, or airway. O2 sat 100%. No rash or itching. She stated she did not eat breakfast except some chocolate, and mother states that she was highly anxious about receiving vaccine. Within 5 mn patient of returning to clinic, patient was feeling much better. Given crackers to eat. O2 sat remained at 100%. BP 107/74, pulse 73 and regular. Denied any lightheadedness, no shortness of breath or throat swelling, and no rash or itching developing. Left walking independently, without difficulty and denies dizziness.  Phone call to mother 11/10/13 in the morning reports that patient had no further adverse effects after leaving clinic, felt fine since leaving clinic.
This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported.On 02-AUG-2017, the patient received an improperly stored dose in immunization series of RECOMBIVAX HB injection (lot # M046373 with expiration date at 04-NOV-2018; strength, exact dose, route of administration and anatomical location were not reported), for prophylaxis. The administered dose of vaccine was exposed to a temperature of 32 degrees Fahrenheit (F) for 168 hours. There was no previous temperature excursion. Data logger was not used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several report received form the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA004072: US-009507513-1708USA004070: US-009507513-1708USA004071: US-009507513-1708USA003345.
patient received vaccine at 10:55am, waited 15 minutes, stated she felt fine, left the facility. at 12:22pm a representative called on behalf of the patient because the patient speaks broken english. the representative stated the patient was experiencing an itchy mouth and ears and sweating profusely. I asked if the patient was having shortness of breath.  The representative replied that they were texting back and forth and when she asked her that question the patient responded "in my chest". I advised that the patient call 911 or seek immediated medical attention
cough; runny nose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (cough) and RHINORRHOEA (runny nose) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cough and Sneezing. Concomitant products included CODEINE PHOSPHATE, PROMETHAZINE HYDROCHLORIDE (PROMETHAZINE WITH CODEINE) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced COUGH (cough) and RHINORRHOEA (runny nose). The patient was treated with CODEINE PHOSPHATE, GUAIFENESIN, PHENIRAMINE MALEATE (ROBITUSSIN WITH CODEINE) at an unspecified dose and frequency. At the time of the report, COUGH (cough) and RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On Day 4 after vaccination (on April 2), April 6, I developed Shingles.  I noticed them at night.  Took 5 painful days to find out it is Shingles.  Doctor confirmed  and put me on 7 days of Valacyclovir treatment.  (I am on Day 6 of treatment).  I never had Shingles before.  I take no regular, long term medication.
I've been having headaches on and off since the COVID shot.  Am starting meds for migraines at this point since I cant function properly in my daily work due to the headaches. No major history of this in the past.
States took the CoVid vaccine a week ago in his rt arm (Not currently in LINKS). Began with facial droop and numbness  - did have a hx of Bells palsy 12 years ago. Obvious facial asymmetry noted with nerve paralysis on the right and is unable to fully close eyelid and the side of his moth is drooping and unable to close completely.
This spontaneous report as received from nurse refers to a 71 year old male patient. The patient's medical history included lymphoma. There was no drug reactions/allergies. On 20-OCT-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 injection, (lot # K009809, expiration date: 16-MAY-2015, strength and dose unknown) intramuscularly. Concomitant therapies included influenza virus vaccine (unspecified) (also reported as none) started on 20-OCT-2014. On 24-OCT-2014, the patient came back to the office because the arm in which he received the PNEUMOVAX 23 was inflamed down to his wrist. The patient sought medical attention. The reporter stated that they drew a circle around the inflamed area and sent the patient home with BACTRIM. The reporter stated later that day, 24-OCT-2014, the patient's wife called and said that the inflamed area began to extend beyond the circle. It was recommended that patient go to the Hospital - which he did on 24-OCT-2014. While at the emergency room, patient had an ultrasound performed which showed negative for a blood clot. Patient was then discharged to home on 24-OCT-2014. The outcome of the event was not provided. Additional information has been requested.
Pt presents on 2/21/13 with c/o redness and tenderness at site of (L) deltoid immunization. She first noticed redness in the morning. Somewhat irregularly shaped though well circumscribed erythematous macule on (L) anterior deltoid roughly 10 cm x 8 cm no increase temp or drainage. She is instructed to use Cephalexin 500 mg TID x 10 days if redness spread.
w/in 48hr post vax pt felt feverish, diarrhea, thirsty, nausea;devel three fever blisters on lower lip (painful) x 4-5 days;fatigue;